We are near the end of the annual open enrollment period for Medicare Advantage. While current fee-for-service beneficiaries can take this opportunity to join an MA plan, it is also a chance for those beneficiaries already in a plan to switch. Different plans may have different costs and other advantages or disadvantages for a beneficiary and there are tools available to help people do this analysis. So how often do people actually switch? A timely Kaiser Family Foundation analysis examines this question. (KFF Analysis) The analysis covers open enrollment periods from 2007 to 2016 and looks at plan-switching for both Medicare Advantage plans that include drug coverage and standalone drug plans. During the 2016 open enrollment period only 7.6% of MA enrollees without a low-income subsidy switched to another MA plan and .9% switched back to traditional Medicare. In that year 8.3% of drug plan enrollees who were not eligible for the low-income subsidy switched to a different stand-alone drug plan and 1.7% went to a full MA plan. There is another roughly 8% of MA members and 3% of drug plan members whose current plan terminates but they are automatically switched to a new plan from the same insurer. These numbers were consistent with the earlier open enrollment periods in the study time frame and the great majority of Medicare Advantage members have never switched plans. In fact in 2017, 45% of people on Medicare said they never look at their Medicare options, and 57% of those over age 85 were in this group. 35% of beneficiaries said it is hard to compare options, a share that was higher for sicker beneficiaries. Now most people could stay in their plans because they are satisfied with them, but low switching rates could also be due to the difficulty of comparing and making a selection. Other research has suggested that many beneficiaries are not in an optimal plan for their situation. This inertia is good for the insurers–it lowers their overall cost of sales and marketing, but it may not be best for consumers. Other tools or processes may be needed to help beneficiaries make more active and informed choices.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Now here is a tale from the glory days of epidemic investing, as the Feds pumped trillions into the economy and a lot of it went to investing, some to...
January 10, 2023
Another merger of two struggling “digital” health companies, which use virtual reality as a product design. Apparently you are less likely to drown in high seas when you are holding...
December 18, 2022
Mercer, a large benefits consulting firm, confirms that health plan premiums are rising in 2023, publishing survey results showing that employers expect an increase of costs by at least 5%....
December 9, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace